Putyrskiĭ L A, Volchenko N N
Sov Med. 1991(11):29-32.
In 1989 the P. A. Hertzen Moscow Research Cancer Institute initiated a trial of high-energy CO2-laser in surgical treatment of breast cancer. Altogether 180 operations were performed. The data are presented on specific features of the laser incision and related breast tissue destruction, factors responsible for variations in the above parameters, laser scalpel advantages.